Analysis of Genetic Alterations in Renal Cell Carcinoma Using the Polymerase Chain Reaction

Overview

Journal Virchows Arch

Specialties Cell Biology
Molecular Biology
Pathology

Date 1994 Jan 1

PMID 8032525

Citations 4

Authors

Y Suzuki

G Tamura

C Maesawa

T Fujioka

T Kubo

R SATODATE

Affiliations

Soon will be listed here.

Abstract

Very frequent loss of heterozygosity (LOH) on chromosome 3p has been found in human renal cell carcinoma (RCC). In the present study, we examined LOH at the retinoblastoma (RB), mutated in colorectal cancer (MCC) and adenomatous polyposis coli (APC) tumour suppressor genes loci, and mutations of the H-, K-, and N-ras oncogenes. We performed these studies using the polymerase chain reaction (PCR) method followed by restriction fragment length polymorphism (RFLP) and single-strand conformation polymorphism (SSCP) analyses. LOH was detected in 2 of 11 (18.2%), and 2 of 14 (14.3%) informative cases at the MCC and APC loci, respectively, and in none of 15 informative cases at the RB locus in 25 RCCs. LOH at the MCC was accompanied by LOH at the APC locus in two RCCs. No mutation was detected in H-, K-, and N-ras genes in 39 RCCs. Thus, alterations of the known tumour suppressor genes and the ras oncogenes were infrequent events in RCC. The results suggest that the genetic pathway in the genesis of RCC differs considerably from that of other common human carcinomas.

Citing Articles

Wnt signaling pathways in urological cancers: past decades and still growing.

Majid S, Saini S, Dahiya R Mol Cancer. 2012; 11:7.

PMID: 22325146 PMC: 3293036. DOI: 10.1186/1476-4598-11-7.

Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models.

Matsuo T, Nishizuka S, Ishida K, Iwaya T, Ikeda M, Wakabayashi G BMC Res Notes. 2011; 4:140.

PMID: 21554739 PMC: 3118158. DOI: 10.1186/1756-0500-4-140.

Detection of loss of heterozygosity in the APC tumor suppressor gene in nonpapillary renal cell carcinoma by microdissection and polymerase chain reaction.

Bohm M, Wieland I, Stinhofer C, Otto T, Rubben H Urol Res. 1997; 25(3):161-5.

PMID: 9228666 DOI: 10.1007/BF00941976.

Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate.

Nishiyama Y, Suwa H, Okamoto K, Fukumoto M, Hiai H, Toyokuni S Jpn J Cancer Res. 1995; 86(12):1150-8.

PMID: 8636003 PMC: 5920660. DOI: 10.1111/j.1349-7006.1995.tb03308.x.

References

Murakami Y, Hayashi K, Hirohashi S, Sekiya T . Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 1991; 51(20):5520-5. View

Bos J, Fearon E, Hamilton S, Verlaan-de Vries M, VAN Boom J, Van Der Eb A . Prevalence of ras gene mutations in human colorectal cancers. Nature. 1987; 327(6120):293-7. DOI: 10.1038/327293a0. View

Mizuuchi H, Nasim S, Kudo R, Silverberg S, Greenhouse S, Garrett C . Clinical implications of K-ras mutations in malignant epithelial tumors of the endometrium. Cancer Res. 1992; 52(10):2777-81. View

Uchida T, Wada C, Shitara T, Egawa S, Mashimo S, Koshiba K . Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma. J Urol. 1993; 150(4):1298-301. DOI: 10.1016/s0022-5347(17)35764-6. View

Slamon D, DeKernion J, Verma I, Cline M . Expression of cellular oncogenes in human malignancies. Science. 1984; 224(4646):256-62. DOI: 10.1126/science.6538699. View

Fujita J, Kraus M, Onoue H, Srivastava S, Ebi Y, Kitamura Y . Activated H-ras oncogenes in human kidney tumors. Cancer Res. 1988; 48(18):5251-5. View

Kovacs G, Szucs S, de Riese W, Baumgartel H . Specific chromosome aberration in human renal cell carcinoma. Int J Cancer. 1987; 40(2):171-8. DOI: 10.1002/ijc.2910400208. View

Rodenhuis S, van de Wetering M, Mooi W, Evers S, van Zandwijk N, Bos J . Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med. 1987; 317(15):929-35. DOI: 10.1056/NEJM198710083171504. View

Vogelstein B, Fearon E, Hamilton S, Kern S, Preisinger A, Leppert M . Genetic alterations during colorectal-tumor development. N Engl J Med. 1988; 319(9):525-32. DOI: 10.1056/NEJM198809013190901. View

10.

Tamura G, Maesawa C, Suzuki Y, Ogasawara S, Terashima M, Saito K . Primary gastric carcinoma cells frequently lose heterozygosity at the APC and MCC genetic loci. Jpn J Cancer Res. 1993; 84(10):1015-8. PMC: 5919060. DOI: 10.1111/j.1349-7006.1993.tb02794.x. View

11.

Ogawa O, Habuchi T, Kakehi Y, Koshiba M, Sugiyama T, Yoshida O . Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p. Cancer Res. 1992; 52(7):1881-5. View

12.

Hollstein M, Sidransky D, Vogelstein B, Harris C . p53 mutations in human cancers. Science. 1991; 253(5015):49-53. DOI: 10.1126/science.1905840. View

13.

Morita R, Ishikawa J, Tsutsumi M, Hikiji K, Tsukada Y, Kamidono S . Allelotype of renal cell carcinoma. Cancer Res. 1991; 51(3):820-3. View

14.

Boynton R, Blount P, Yin J, Brown V, Huang Y, Tong Y . Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci U S A. 1992; 89(8):3385-8. PMC: 48872. DOI: 10.1073/pnas.89.8.3385. View

15.

Nanus D, Mentle I, Motzer R, Bander N, Albino A . Infrequent ras oncogene point mutations in renal cell carcinoma. J Urol. 1990; 143(1):175-8. DOI: 10.1016/s0022-5347(17)39905-6. View

16.

Saiki R, Gelfand D, Stoffel S, Scharf S, Higuchi R, Horn G . Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988; 239(4839):487-91. DOI: 10.1126/science.2448875. View

17.

Lee E, To H, Shew J, Bookstein R, Scully P, Lee W . Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science. 1988; 241(4862):218-21. DOI: 10.1126/science.3388033. View

18.

Ishikawa J, Xu H, Hu S, Yandell D, Maeda S, Kamidono S . Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res. 1991; 51(20):5736-43. View

19.

ROBSON C, Churchill B, Anderson W . The results of radical nephrectomy for renal cell carcinoma. J Urol. 1969; 101(3):297-301. DOI: 10.1016/s0022-5347(17)62331-0. View

20.

DAmico D, Carbone D, Johnson B, Meltzer S, Minna J . Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. Cancer Res. 1992; 52(7):1996-9. View